Sigyn Therapeutics Balance Sheet (2016-2025)

Reported Financials

Sigyn Therapeutics Quarterly Balance Sheet

Periods 37 quarters

Latest Sep 2025

Sigyn Therapeutics reported total assets of $0.14M and total liabilities of $6.05M for the quarter ended Sep 2025, down 68.3% year over year. This balance sheet covers 37 quarters of results from Mar 2016 through Sep 2025, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	0.08M	0.01M	1.06M	0.50M	0.34M	0.08M	0.01M	0.03M	0.01M	0.32M	0.02M	0.06M	0.01M	0.03M	0.05M	0.16M	0.01M	0.01M	459.00	0.09M
Cash & Current Investments	0.08M	0.01M	1.06M	0.50M	0.34M	0.08M	0.01M	0.03M	0.01M	0.32M	0.02M	0.06M	0.01M	0.03M	0.05M	0.16M	0.01M	0.01M	459.00	0.09M
Receivables - NetNet Receivables
Receivables
Raw Materials
Work In Process
Finished Goods
Inventory	0.59M	0.59M	0.59M	0.59M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M	0.05M
Prepaid Assets			0.03M	0.03M	0.00M	0.01M	0.05M	0.01M	0.01M	0.04M	0.06M	0.05M	0.06M	0.05M	0.04M	0.05M	0.01M	0.06M	0.00M
Current Assets	0.67M	0.59M	1.67M	1.12M	0.39M	0.14M	0.10M	0.09M	0.07M	0.41M	0.13M	0.17M	0.12M	0.13M	0.15M	0.27M	0.02M	0.07M	0.00M	0.09M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.00M	0.00M	0.00M	0.02M	0.03M	0.03M	0.03M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M
Goodwill
Intangibles	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Goodwill & Intangibles	0.02M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Other Non-Current Assets			0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.07M	0.07M	0.05M	0.05M
Non-Current Assets	0.02M	0.02M	0.32M	0.32M	0.32M	0.30M	0.29M	0.28M	0.26M	0.25M	0.23M	0.22M	0.20M	0.19M	0.17M	0.16M	0.19M	0.18M	0.05M	0.05M
Assets	0.69M	0.61M	1.99M	1.44M	0.71M	0.45M	0.40M	0.36M	0.33M	0.66M	0.36M	0.39M	0.32M	0.32M	0.32M	0.43M	0.21M	0.24M	0.05M	0.14M
Liabilities
Current Liabilities
Accounts Payables	0.02M	0.04M	0.04M	0.03M	0.04M	0.20M	0.30M	0.31M	0.33M	0.27M	0.34M	0.36M	0.46M	0.53M	0.49M	0.61M	0.61M	0.67M	0.73M	0.77M
Notes Payables	0.52M	0.58M	0.62M	0.68M	0.65M	0.70M	0.95M	1.52M	1.64M	2.47M	2.63M	2.95M	1.89M	2.48M	1.78M	1.79M	1.89M	2.19M	2.31M	2.51M
Payables	0.53M	0.62M	0.66M	0.72M	0.69M	0.90M	1.24M	1.82M	1.96M	2.74M	2.97M	3.31M	2.35M	3.01M	2.27M	2.40M	2.50M	2.86M	3.04M	3.28M
Accumulated Expenses	0.06M	0.06M	0.06M	0.04M	0.00M		0.07M	0.03M	0.03M	0.04M	0.19M	0.41M	0.79M	1.08M	1.49M	1.76M	1.87M	2.01M	2.19M	2.28M
Other Accumulated Expenses	523.00	0.00M	0.00M	0.03M	179.00	0.00M			0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	48.00	0.00M	312.00	0.00M	0.00M
Short term Debt																	0.17M	0.21M	0.26M	0.30M
Current Leases			0.03M	0.04M	0.05M	0.05M	0.05M	0.05M	0.05M	0.06M	0.06M	0.06M	0.06M	0.06M	0.07M	0.07M	0.07M	0.07M
Current Deferred Revenue
Total Current Liabilities	0.59M	0.69M	0.75M	0.83M	0.73M	0.95M	1.36M	1.90M	2.05M	2.83M	3.25M	3.82M	3.61M	4.23M	3.90M	4.28M	4.61M	5.15M	5.49M	3.99M
Non-Current Liabilities
Non-Current Debt																	1.89M			2.51M
Convertible Debt
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
Operating Leases			0.26M	0.25M	0.24M	0.28M	0.26M	0.25M	0.19M	0.23M	0.22M	0.20M	0.13M	0.17M	0.16M	0.14M	0.06M	0.11M
Other Non-Current Liabilities																				0.18M
Total Non-Current Liabilities			0.26M	0.25M	0.24M	0.23M	0.22M	0.20M	0.19M	0.17M	0.16M	0.14M	0.13M	0.11M	0.09M	0.07M	0.06M	0.04M		2.06M
Total Liabilities	0.59M	0.69M	1.02M	1.08M	0.97M	1.18M	1.58M	2.10M	2.24M	3.01M	3.40M	3.96M	3.73M	4.34M	3.99M	4.35M	4.67M	5.19M	5.49M	6.05M
Shareholder's Equity
Total Debt	0.52M	0.58M	0.62M	0.68M	0.65M	0.70M	0.95M	1.52M	1.64M	2.47M	2.63M	2.95M	1.89M	2.48M	1.78M	1.79M	3.96M	2.40M	2.57M	5.32M
Common Equity	0.10M	-0.08M	0.98M	0.36M	-0.26M	-0.73M	-1.18M	-1.74M	-1.90M	-2.35M	-3.04M	-3.58M	-3.41M	-4.02M	-3.67M	-3.92M	-4.46M	-4.95M	-5.44M	-5.92M
Liabilities and Shareholders Equity	0.69M	0.61M	1.99M	1.44M	0.71M	0.45M	0.40M	0.36M	0.33M	0.66M	0.36M	0.39M	0.32M	0.32M	0.32M	0.43M	0.21M	0.24M	0.05M	0.14M
Retained Earnings	-1.26M	-1.72M	-2.37M	-3.04M	-4.27M	-4.94M	-5.61M	-6.34M	-7.20M	-8.54M	-9.26M	-10.17M	-11.34M	-12.10M	-12.96M	-14.16M	-14.68M	-15.35M	-16.80M	-17.38M
Preferred Shares

Sigyn Therapeutics SIGY Balance Sheet (2016-2025)

Sigyn Therapeutics Quarterly Balance Sheet

Create an account

Sign In

Reset Password